Compare NOVTU & BLRKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOVTU | BLRKU |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 3000 | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Miscellaneous | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2025 |
| Metric | NOVTU | BLRKU |
|---|---|---|
| Price | $55.51 | $10.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 8.6K | 1.8K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.57 | $9.98 |
| 52 Week High | $64.51 | $10.99 |
| Indicator | NOVTU | BLRKU |
|---|---|---|
| Relative Strength Index (RSI) | 36.89 | 54.63 |
| Support Level | $51.68 | $9.98 |
| Resistance Level | $56.91 | $10.99 |
| Average True Range (ATR) | 1.24 | 0.08 |
| MACD | -0.74 | 0.00 |
| Stochastic Oscillator | 0.00 | 5.94 |
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Bluerock Acquisition Corp is a blank check company incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.